Carlo Kaizzer A.

Lu OB WARD 6-2pm
III-DN4 Dec 6-8, 2010
DRUG STUDY – UNIVERSITY OF MAKATI
Drug name Classificatio Action Route, Contraindica Nursing consideration Evaluation
n dosage, tion
frequency
 Carlo Kaizzer A. Lu OB WARD 6-2pm
III-DN4 Dec 6-8, 2010
DRUG STUDY – UNIVERSITY OF MAKATI

Brand Nonsteroidal Inhibits 50mg IV q8 - • Patients who have asthma, Effectivity

name: anti- prostaglandin Hypersensitivit aspirin-induced allergy, and of the drug
Toradol inflammatory synthesis y nasal polyps are at increased was
agents, ↓ - Cross- risk for developing evidenced
Generic nonopioid producing sensitivity with hypersensitivity reactions. by
name: analagesics peripherally other NSAIDs Assess for rhinitis, asthma, and decreased
ketorolac mediated may exist¨Pre- urticaria. in pain
analgesia or
↓ perioperative • Assess pain (note type,
Decreased pain use location, and intensity) prior to
- Known and 1-2 hr following
alcohol administration.
intoleranceUse
cautiously in: • Ketorolac therapy should
1) History of GI always be given initially by the
bleeding IM or IV route. Oral therapy
2) Renal should be used only as a
impair-ment continuation of parenteral
(dosage therapy.
reduction may
be required) • Caution patient to avoid
3) concurrent use of alcohol,
Cardiovascular aspirin, NSAIDs, acetaminophen,
disease or other OTC medications
without consulting health care
professional.

• Advise patient to consult if

rash, itching, visual
disturbances, tinnitus, weight
gain, edema, black stools,
persistent headche, or influenza-
like syndromes
(chills,fever,muscles aches, pain)
Carlo Kaizzer A. Lu OB WARD 6-2pm
III-DN4 Dec 6-8, 2010
DRUG STUDY – UNIVERSITY OF MAKATI
occur.
• Effectiveness of therapy
can be demonstrated by
decrease in severity of pain.
Patients who do not respond to
one NSAIDs may respond to
another.